Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vargatef in Ovarian Cancer (CHIVA)
NCT01583322Phase 2Completed
- Sponsor
- ARCAGY
- Start
- Jun 2012
- Primary completion
- May 2015
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of nintedanib in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by ARCAGY. Started Jun 2012; status: completed.
02
Drugs
nintedanib
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT01583322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01583322.